Conference Coverage
Conference Coverage
Vaporized Cannabis for Acute Migraine Yields Rapid, Sustained Relief
“In this single-center randomized controlled trial across 247 treated migraine attacks, four puffs of vaporized THC-CBD mix were efficacious for...
Conference Coverage
IV Ketamine Promising for Severe Refractory Headache in Children
Overall, the treatment was “safe and well tolerated.”
Conference Coverage
First Long-Term Data on Atogepant for Migraine Prevention
“This is the first long-term study for assessing the safety and efficacy of a drug belonging to the gepant class.”
Conference Coverage
Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide
The results underscore the need for psychiatric evaluations in patients with a headache disorder.
Conference Coverage
Is Migraine a Forerunner of Multiple Sclerosis?
“The inflammatory setting of the first MS relapse might be actually triggering the migraine.”
Conference Coverage
Building a Toolkit for the Treatment of Acute Migraine
Conference Coverage
PFO closure may reduce migraine days and prevent stroke
After some negative studies with PFO closure, attention is returning to this strategy for migraine prevention.
Conference Coverage
Drugs to prevent versus those to treat migraine might not share targets
The distinct molecular events in each phase of migraine suggest the prevention and treatment targets differ.
Conference Coverage
Adolescents with migraine need smooth handoff to adult care
One goal of migraine management in adolescents and young adults should be to prevent adulthood chronicity.
Conference Coverage
Avoid adding to minority stress when treating headache in LGBTQIA+ patients
To address headache in LBGTQIA+ patients, inclusive behavior can set the stage of collaboration toward control.